Fact CheckerSign in

NCT06413641Active, not recruiting

VIsualization of Coronary Artery Disease for Modification of RISK Factors

VIsualization of Coronary Artery Disease for Modification of RISK Factors. Prevention of Disease Progression in Patients With Non-Obstructive Coronary Atherosclerosis.

Source: ClinicalTrials.gov · Last updated 6 May 2026

Brief summary (registry, in English)

The VICAD-RISK study assesses if visualization of coronary CT angiography (CTA) images in participants with non-obstructive coronary artery disease will improve LDL lowering, reduce reporting of side effects by cholesterol lowering medications, and modify the coronary artery disease phenotype over 12 months.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
273 (estimated)
First submitted
12 Apr 2024
Start date
12 Mar 2024
Primary completion date
15 May 2025
Lead sponsor
Aarhus University Hospital
NCT number
NCT06413641

What you commit to

  • Study type: Interventional
  • Planned participants: 273
  • From 12 Mar 2024 to the primary completion date, 15 May 2025
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Ongoing lipid lowering medical treatment (Patients already on lipid lowering medical therapy can be included if the treatment was initiated \<3 months before the time of the CTA test)

Other illness

  • Obstructive coronary disease (One or more coronary stenosis ≥70%, left main \>40%)
  • Allergy to iodinated contrast media
  • Contraindications to statins (Active liver disease Child-Pugh A, B and C, excessive alcohol consumption)
  • Participation in a cardiac rehabilitation or lifestyle modification program

Lab values

  • Renal insufficiency (eGFR \<40 ml/min)

Other

  • Post CTA test indication for invasive coronary angiography
  • Non-evaluable CTA exam
  • BMI \>40
  • Pregnancy

Who the study is looking for

  • New diagnosis of nonobstructive coronary artery disease
  • No known coronary artery disease (no previous coronary revascularization)
  • Coronary Artery Disease Reporting and Data System (CAD-RADS) score 1-3
  • LDL cholesterol \> 2.0 mmol/l
  • Life expectancy \>3 years
  • Signed informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Aalborg University Hospital
Coordinator of this site? Confirm its status
AalborgDenmarkUnknown status
Bjarne L Nørgaard
Coordinator of this site? Confirm its status
AarhusDenmarkUnknown status
Hospital of South West Jutland
Coordinator of this site? Confirm its status
EsbjergDenmarkUnknown status
Gødstrup Hospital
Coordinator of this site? Confirm its status
GødstrupDenmarkUnknown status
Vejle Hospital
Coordinator of this site? Confirm its status
VejleDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.